Delisting of Securities of BIND Therapeutics, Inc., InterCloud Systems, Inc., Echo Therapeutics, Inc., 1347 Capital Corp., and EPIRUS Biopharmaceuticals, Inc. from The Nasdaq Stock Market


NEW YORK, Sept. 23, 2016 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of BIND Therapeutics, Inc. BIND Therapeutics, Inc.’s stock was suspended on August 01, 2016 and has not traded on Nasdaq since that time.

Nasdaq also announced that it will delist the common stock and warrant of InterCloud Systems, Inc. InterCloud Systems, Inc’s common stock and warrant were suspended on August 31, 2016 and have not traded on Nasdaq since that time.

Nasdaq also announced that it will delist the common stock of Echo Therapeutics, Inc. Echo Therapeutics, Inc.’s stock was suspended on July 12, 2016 and has not traded on Nasdaq since that time.

Nasdaq also announced that it will delist the common stock, warrant, unit and right of 1347 Capital Corp. 1347 Capital Corp.’s common stock, warrant, unit and right were suspended on July 12, 2016 and have not traded on Nasdaq since that time.

Finally, Nasdaq announced that it will delist the common stock of EPIRUS Biopharmaceuticals, Inc. EPIRUS Biopharmaceuticals, Inc.’s stock was suspended on August 04, 2016 and has not traded on Nasdaq since that time.

Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting for each of these companies.  The delistings become effective ten days after the Form 25 is filed.  For news and additional information about the companies, including the basis for the delistings and whether the companies’ securities are trading on another venue, please review the companies’ public filings or contact the company directly.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: http://www.cchwallstreet.com/NasdaqTools/bookmark.asp?id=nasdaq-rule_5800&manual=/nasdaq/main/nasdaq-equityrules/.

NDAQO